Align Technology (ALGN) Stock Price, News & Analysis

Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company in the manufacturing sector, classified under surgical appliance and supplies manufacturing. The company designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry. These offerings are described by Align as technology building blocks that enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for hundreds of thousands of doctor customers worldwide.

Align states that over the past 28 years it has helped doctors treat more than 21.4 million patients with the Invisalign System and that its customer base includes approximately 291 thousand doctor customers. The company highlights a global consumer market opportunity of around 600 million consumers for its solutions. Align Technology is regularly described in its news releases as a leading global medical device company that trades on the NASDAQ Global Select Market under the ticker ALGN.

Core business and product ecosystem

The core of Align's business is the Invisalign System of clear aligners, which is used by orthodontists and general practitioner (GP) dentists to treat malocclusions and straighten teeth. Invisalign is Align's main product and was approved by the U.S. Food and Drug Administration in 1998. Invisalign has treated tens of millions of patients since launch and can address a large proportion of malocclusion cases. Align also offers specialized Invisalign options, such as systems with mandibular advancement featuring occlusal blocks, designed for Class II skeletal and dental correction in growing patients, as described in recent news about commercial availability in markets such as Thailand and the Philippines.

Beyond clear aligners, Align sells iTero intraoral scanners, which capture digital impressions of patients' teeth and support treatment planning. Align Technology Inc's Invisalign cases are submitted by digital scans in over 85% of cases, and iTero scans make up a substantial share of those submissions. Align also owns exocad CAD/CAM software, which supports dental laboratories and clinicians with digital design tools. Together, Invisalign, iTero, and exocad are repeatedly described by the company as key elements of the Align™ Digital Platform, an integrated suite of proprietary technologies and services that connects patients, consumers, orthodontists, GP dentists, and lab partners.

Digital orthodontics and restorative workflows

Align emphasizes its role in digital dentistry and digital orthodontics. The Align Digital Platform is described as a combination of software, systems, and services that provides an end-to-end workflow across diagnosis, planning, treatment, and monitoring. Examples from recent announcements include:

• ClinCheck® treatment planning software and the ClinCheck signature experience, which provide cloud-based tools, automated Invisalign Personalized Plan templates, and real-time 3D controls for doctors.
• ClinCheck® Live Plan, a feature that automates the generation of initial, doctor-ready Invisalign treatment plans in about 15 minutes for eligible cases, using Align's proprietary data and algorithms.
• Invisalign® Outcome Simulator Pro and Smile Video, which generate in-face visualizations of potential treatment outcomes to support patient communication and treatment acceptance at chairside.
• iTero™ Design Suite, which supports chairside design and integration with 3D printers and milling systems for models, bite splints, mock-ups, and other restorations.
• Align™ Oral Health Suite, which offers comparison tools and oral health reports to support multi-modality assessments and doctor–patient conversations.

These tools are positioned by Align as ways to enhance practice workflows, increase patient engagement, and support the adoption of Invisalign treatment and other restorative procedures.

Customer base and clinical focus

Across multiple news releases, Align states that it serves approximately 291 thousand doctor customers globally. These customers include orthodontists, general practitioner dentists, and dental laboratories that use Invisalign clear aligners, iTero scanners, and exocad software. The company highlights solutions for a range of patient groups, including adults, teens, and children, and notes specific offerings for growing patients, such as the Invisalign System with mandibular advancement featuring occlusal blocks and products like Invisalign First™ and the Invisalign Palatal Expander System.

Align's communications also reference support for doctors treating patients who may not be well-suited for fixed appliances due to health issues, allergies, disabilities, or specific health disorders, through discounted fees and product donation programs. Initiatives such as Acts of Random Kindness (ARK) and partnerships with organizations like Smiles4Canada, Smiles Change Lives, and Smile for a Lifetime are cited as ways the company supports access to orthodontic care for children and teens from families with financial need.

Research, education, and professional engagement

Align Technology operates an Annual Research Award Program that provides funding to university faculty for clinical and scientific research in orthodontics and dentistry. The company states that this program has funded millions of dollars in research since its inception and that awards are available across regions including the Americas, EMEA, and APAC. Applications are reviewed by an independent academic committee before final selection.

In addition to research funding, Align participates in major dental and healthcare conferences and hosts its own educational events. Examples include participation in the Greater New York Dental Meeting, the Invisalign GP Summit, and various global healthcare investor conferences. At such events, Align and its exocad subsidiary showcase new software releases, scanner innovations, and digital workflow tools, and sponsor clinical education sessions focused on topics such as practice productivity, diagnosis and case planning, and integrating orthodontic and restorative treatment.

Financial reporting and regulatory status

Align Technology files regular reports and current reports with the U.S. Securities and Exchange Commission. Recent Form 8-K filings reference the announcement of quarterly financial results and changes in executive leadership and board composition. The filings list the company as trading on the NASDAQ Global Select Market and provide a corporate address in Tempe, Arizona. There is no indication in the provided filings of delisting, deregistration, bankruptcy, or a completed merger or acquisition that would change the company's independent operating status.

The company issues detailed quarterly earnings press releases, such as the third quarter 2025 financial results, which discuss revenues, clear aligner volumes, imaging systems and CAD/CAM services revenues, operating margins, cash balances, stock repurchases, restructuring charges, and business outlook. These releases also highlight geographic trends and product category performance, as well as updates on tariffs, tax matters, and restructuring initiatives.

Innovation and intellectual property

Align's announcements emphasize ongoing research and development and the use of proprietary technologies. The company notes that ClinCheck Live Plan is built on proprietary data and algorithms derived from decades of research and the experience of doctors who have treated more than 21 million Invisalign patients worldwide. It also references the use of patented materials such as SmartTrack™ for aligners and proprietary technologies like SmartForce™ features and SmartStage™ technology, which are described as supporting predictable tooth movement in Invisalign treatment.

Align also discloses legal actions related to intellectual property, including complaints and lawsuits filed against other clear aligner manufacturers alleging patent infringement and unfair competition in the importation and sale of clear aligners. These actions underscore the company's focus on protecting its technology and brand.

Social and community initiatives

Beyond its commercial activities, Align highlights several social impact initiatives. Through partnerships with organizations such as the Canadian Foundation for the Advancement of Orthodontics (CFAO) and programs like Smiles4Canada, the company sponsors Invisalign treatment for children and teens with significant orthodontic needs whose families lack financial resources. Align notes that it has waived lab fees for hundreds of patients through its Acts of Random Kindness program and collaborates with Invisalign-trained doctors who donate their time and practice resources.

These initiatives are presented as part of Align's broader engagement with the orthodontic profession and its support for access to quality orthodontic care in multiple regions, including Canada, the United States, EMEA, and Australia.

Summary

According to its own disclosures and public communications, Align Technology, Inc. is a global medical device manufacturer focused on clear aligner therapy, intraoral scanning, and digital dental design software. Through the Invisalign System, iTero scanners, exocad software, and the Align Digital Platform, the company aims to support digital orthodontic and restorative workflows for a large base of doctor customers worldwide. Its activities span product development, digital workflow innovation, research funding, professional education, and community-focused programs that expand access to orthodontic care.